Our Pricing

Can You Get Mounjaro on NHS? Your Complete UK Guide

If you're wondering can you get Mounjaro on NHS, the answer depends on your individual circumstances and local prescribing policies. While Mounjaro (tirzepatide) is licensed by the MHRA for weight management in the UK, NHS availability remains limited, with many patients turning to regulated private pharmacies like Cured Pharmacy for access from £135.00.

Current NHS Availability of Mounjaro for Weight Loss

Mounjaro received UK marketing authorisation from the MHRA in November 2023 for chronic weight management in adults with a body mass index (BMI) of 30 kg/m² or greater, or 27 kg/m² with weight-related comorbidities [1]. However, NICE (National Institute for Health and Care Excellence) guidance on NHS funding determines whether local health authorities will commission the treatment.

As of 2025, most NHS Integrated Care Boards (ICBs) have not routinely funded Mounjaro for weight management due to budget constraints and ongoing health technology assessments. Some specialist NHS weight management services may prescribe tirzepatide in exceptional circumstances, but availability varies significantly across England, Scotland, Wales, and Northern Ireland.

Patients seeking Mounjaro through the NHS typically require referral to a specialist weight management clinic, where eligibility is assessed against strict criteria including previous weight loss attempts, documented lifestyle interventions, and specific BMI thresholds. Waiting times for these specialist services can extend beyond 12 months in many regions.

NHS Eligibility Criteria vs Private Prescription Requirements

For the limited NHS services offering Mounjaro, eligibility typically requires a BMI of 35 kg/m² or above (or 32.5 kg/m² for patients from South Asian, Chinese, Black African, or African-Caribbean backgrounds), alongside documented evidence of at least two previous weight management interventions and participation in a structured lifestyle programme [2].

Private prescription pathways through UK-registered pharmacies like Cured Pharmacy follow MHRA-licensed prescribing criteria, which generally require a BMI of 30 kg/m² or greater, or 27 kg/m² with at least one weight-related comorbidity such as hypertension, type 2 diabetes, or dyslipidaemia. All patients complete a clinical assessment by a UK-registered prescriber before treatment can be dispensed.

The private route offers significantly faster access—typically within 24-48 hours of clinical approval—compared to NHS waiting lists. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) oversees all clinical assessments to ensure safe, appropriate prescribing in line with current UK guidelines.

What the Clinical Assessment Involves

Whether accessing Mounjaro privately or through the NHS, you'll undergo a thorough medical assessment covering your weight history, previous weight loss attempts, current medications, cardiovascular health, and any contraindications. UK prescribers must verify that tirzepatide is clinically appropriate and that you understand the commitment to long-term treatment alongside lifestyle modifications.

How Mounjaro Works: The Science Behind Tirzepatide

Mounjaro contains tirzepatide, the first dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK [1]. This dual mechanism distinguishes it from single-pathway GLP-1 treatments like semaglutide (Wegovy) and liraglutide (Saxenda).

By activating both GIP and GLP-1 receptors, tirzepatide enhances insulin secretion, suppresses glucagon release, slows gastric emptying, and reduces appetite through central nervous system pathways. In the landmark SURMOUNT-1 trial, participants receiving the 15mg maintenance dose achieved an average body weight reduction of 22.5% over 72 weeks—the highest efficacy demonstrated by any approved obesity medication to date [1][3].

The treatment is administered as a once-weekly subcutaneous injection, starting at 2.5mg and gradually escalating to maintenance doses of 5mg, 10mg, or 15mg depending on individual response and tolerability. This dose titration schedule minimises gastrointestinal side effects whilst optimising therapeutic benefit.

Expected Results and Timeline

Clinical trial data shows that meaningful weight loss typically begins within 4-8 weeks of initiating Mounjaro, with peak effects observed between 60-72 weeks of continuous treatment [3]. However, individual results vary based on baseline BMI, adherence to lifestyle modifications, and metabolic factors. All weight loss medications work best when combined with reduced-calorie nutrition and increased physical activity.

Private Prescription Costs: What to Expect in the UK

At Cured Pharmacy, Mounjaro is available from £135.00 per month, with transparent upfront pricing displayed before you complete your clinical consultation. This represents competitive UK pricing compared to typical market rates, and we guarantee the lowest prices on all genuine UK-licensed medicines.

The total treatment cost depends on your prescribed maintenance dose. Lower doses (2.5mg and 5mg) used during the initial titration phase cost less than higher maintenance doses (10mg and 15mg). Your UK prescriber will determine the appropriate dose progression based on your clinical response and tolerability.

Unlike some providers, we never charge consultation fees, prescription fees, or hidden administration costs. The price you see includes your medication, clinical assessment by a UK prescriber, and discreet next-day delivery across the United Kingdom. Payment plans and subscription options may be available to help manage the cost of long-term treatment.

Mounjaro vs Wegovy vs Saxenda: Comparing Your Options

All three medications are injectable GLP-1 receptor agonists licensed by the MHRA for chronic weight management, but they differ in mechanism, dosing frequency, and clinical efficacy. Mounjaro (tirzepatide) offers dual GIP/GLP-1 action with once-weekly dosing and the highest average weight loss in clinical trials [1][3].

Wegovy (semaglutide) is a once-weekly GLP-1 receptor agonist that demonstrated an average 14.9% body weight reduction over 68 weeks in the STEP-1 trial [4]. Saxenda (liraglutide) requires daily injections and showed an average 8% weight loss over 56 weeks in the SCALE trials [5]. Choice between treatments depends on individual medical history, injection preference, cost considerations, and prescriber assessment.

Some patients who experience inadequate response or tolerability issues with one GLP-1 medication may achieve better results with an alternative. Your UK prescriber will discuss your treatment goals and medical background to recommend the most appropriate option. Switching between treatments requires careful clinical oversight and may involve a washout period.

Non-Injectable Alternatives

For patients who prefer oral medications, options include Orlistat (a lipase inhibitor available from £135.00) and the newly available Wegovy oral tablets (semaglutide pill). Whilst oral alternatives avoid injections, they typically demonstrate lower average weight loss compared to injectable GLP-1 treatments. Your prescriber can advise on the most suitable option based on your clinical profile and preferences.

How to Access Mounjaro Through Cured Pharmacy

Accessing Mounjaro privately through our UK-registered pharmacy (GPhC 9012511) involves three straightforward steps. First, complete our free online consultation, which takes under three minutes and covers your medical history, current medications, weight management goals, and any contraindications. This assessment is reviewed by a UK-registered prescriber who determines whether Mounjaro is clinically appropriate for you.

If approved, your prescription is electronically transmitted to our dispensary where our team prepares your medication for discreet packaging and dispatch. We source all medicines directly from UK-licensed wholesalers and manufacturers, guaranteeing authenticity and regulatory compliance. Every Mounjaro KwikPen is supplied with full patient information leaflets, injection instructions, and sharps disposal guidance.

Orders placed before 3pm on working days are typically dispatched the same day for next-day delivery via tracked courier. All packaging is plain and discreet with no external branding or indication of contents. If you have questions during treatment, our clinical team is available on (+44) 116 4646009 during business hours, and you can request follow-up consultations at any time to discuss dose adjustments or side effects.

Ongoing Monitoring and Support

Safe use of Mounjaro requires ongoing monitoring of weight loss progress, side effects, and metabolic parameters. We recommend regular follow-up consultations every 4-12 weeks, particularly during dose escalation phases. Your prescriber may request updated weight measurements, blood pressure readings, or blood test results to ensure treatment remains appropriate and effective. This collaborative approach optimises outcomes whilst maintaining patient safety.

Scientific References

1. Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen: UK Public Assessment Report. GOV.UK. https://www.gov.uk/government/publications/mounjaro-25-mg-solution-for-injection-in-pre-filled-pen
2. National Institute for Health and Care Excellence. (2023). Obesity: identification, assessment and management (CG189). NICE. https://www.nice.org.uk/guidance/cg189
3. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038
4. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183
5. Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A randomized, controlled trial of 3.0 mg of liraglutide in weight management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.